BayCurrent (6532) · FactDropped
Major customer accounting for 12.0% of revenue: Pfizer Inc.
First written in FY2023. 1 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2025.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Revenue concentration in disease solutions for pharmaceutical companiesA theme 4 companies write about · 4 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Dropped".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025DroppedAnnual report
「As no external customer accounted for 10% or more of revenue in the consolidated fiscal year, this information has been omitted.」
In FY2025, no external customer accounted for 10% or more of revenue, so Pfizer Inc., which accounted for 11.1% of revenue in the previous fiscal year, was no longer subject to disclosure as a major customer. - FY2024AdvancedAnnual report
「Pfizer Inc. 10,468 11.1」
Revenue from Pfizer Inc. increased from ¥9,123 million in the previous year to ¥10,468 million. Its share of total revenue, however, declined from 12.0% to 11.1%. - FY2023First statedAnnual report
「Pfizer Inc. - - 9,123 12.0」
While no customer accounted for 10% or more of revenue in the previous fiscal year, revenue from Pfizer Inc. was ¥9,123 million in the current fiscal year, accounting for 12.0% of total revenue.